Behavioural sciences

Feinstein Institutes awarded $3.4M from Wellcome to study schizophrenia using rTMS therapy

Retrieved on: 
Friday, April 28, 2023
Other Health, Research, Managed Care, General Health, Mental Health, Hospitals, Clinical Trials, Science, Neurology, FDA, Other Science, Health, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Donald, Medicine, Hofstra University, Psychosis, Depression, Tic disorder, OCD, Life, Feinstein Institutes for Medical Research, Silver, Infection, Multimedia, Brain, Disorder, Behavioural sciences, Patient, Psychiatry, Transcranial magnetic stimulation, Feinstein, Climate, Credit, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Mental health, Medical research, Food, World Health Organization, Pharmaceutical industry, MD, Wellcome, Schizophrenia

Researchers at The Feinstein Institutes for Medical Research have received a $3.4 million grant from Wellcome to study repetitive transcranial magnetic stimulation (rTMS) and its effects.

Key Points: 
  • Researchers at The Feinstein Institutes for Medical Research have received a $3.4 million grant from Wellcome to study repetitive transcranial magnetic stimulation (rTMS) and its effects.
  • View the full release here: https://www.businesswire.com/news/home/20230428005023/en/
    Dr. Anil Malhotra will lead a new double-blind, randomized clinical trial that will study if rTMS improves social cognitive performance of people living with schizophrenia over the course of five years.
  • (Credit: Feinstein Institutes)
    Already approved by the U.S. Food and Drug Administration (FDA), rTMS is used to help treat people with depression and obsessive-compulsive disorder (OCD).
  • This is the first time the Feinstein Institutes received funding from Wellcome, a London-based charitable foundation which focuses on funding health research.

RESEARCHERS FIND EARLIER INTERVENTION LEADS TO GREATER IMPROVEMENTS IN YOUNG CHILDREN ON THE AUTISM SPECTRUM

Retrieved on: 
Thursday, April 13, 2023
University, Pediatrics, CHOP, Life, Lord, Florida State University, National Institute of Mental Health, Simons Foundation Autism Research Initiative, Parent, Pediatrics (journal), Development of the human body, Mental health, American Academy, Research, Brain, Adolescence, Doctor of Philosophy, Language, Bentham Science Publishers, Journal of Developmental and Behavioral Pediatrics, Individual, Division, FSU, Randomized controlled trial, Spectrum, Psychiatry, Behavioural sciences, ESI, Human development, Diagnosis, Hospital, Simons Foundation, Hospital Insurance and Diagnostic Services Act, UCLA, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Caregiver, Children's Hospital of Philadelphia, Tutoring, Medical imaging, Nursing, Toy, Residential care, Child

While prior studies provided strong evidence for the benefits of early intervention in autism, many are correlation studies rather than randomized controlled studies that can provide more conclusive results.

Key Points: 
  • While prior studies provided strong evidence for the benefits of early intervention in autism, many are correlation studies rather than randomized controlled studies that can provide more conclusive results.
  • Researchers used the Early Social Interaction (ESI) model, a parent-implemented intervention for toddlers diagnosed with autism that provides a framework to support a child's development in social communication and active engagement.
  • The study found that children who received individualized ESI coaching earlier showed greater gains in use and understanding of language, social use of communication skills, and self-help skills.
  • This research was also supported in part by the funding from Autism Speaks and the Simons Foundation.

Small Pharma Announces Positive Six-month Data from Phase IIa Trial of SPL026

Retrieved on: 
Tuesday, April 4, 2023
Chief scientific officer, DMT, Weill Institute for Cell and Molecular Biology, Depression, University, University of California, San Francisco, Neuroimaging, MDD, Patient, The Retreat, Psychiatry, Behavioural sciences, Phase, Safety, Major depressive disorder, Pharmaceutical industry, N, Neurology

LONDON, April 04, 2023 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “Company” or “Small Pharma”), a biotechnology company focused on short-duration psychedelic-assisted therapies for mental health conditions, today announces positive six-month data from the Company’s Phase IIa clinical trial of SPL026.

Key Points: 
  • LONDON, April 04, 2023 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (the “Company” or “Small Pharma”), a biotechnology company focused on short-duration psychedelic-assisted therapies for mental health conditions, today announces positive six-month data from the Company’s Phase IIa clinical trial of SPL026.
  • New data from the Phase IIa trial shows that among the patients who had achieved remission within three months with SPL026, 64% sustained remission to six months.
  • The trial investigated the efficacy and safety of 21.5mg intravenous (“IV”) SPL026 with supportive therapy in 34 patients with moderate/severe MDD.
  • Dr. Carol Routledge, Chief Medical & Scientific Officer said: “With our ongoing analyses of the Phase IIa trial data, we are increasingly encouraged by the treatment potential of SPL026.

Red Cell Partners Announces $3 Million in Pre-Seed Funding for Psychedelic Company TARA Mind

Retrieved on: 
Thursday, April 13, 2023
Pharmaceutical, Health, Neurology, Mental Health, Red Cell, Partnership, Depression, Icahn School of Medicine at Mount Sinai, Suicide, Integration, Absenteeism, Professional corporation, Health equity, Veteran, Human, Multimedia, Harvard Medical School, Mount Sinai, Doctor of Philosophy, Science, Stanford University School of Medicine, MDD, MD, Post-traumatic stress disorder, Standard of care, Mental, Navy, Traumatic brain injury, Behavioural sciences, PAT, Entrepreneurship, ROI, TRD, Death, Mental health, Society, Fourth Estate Public Benefit Corporation, Safety, Major depressive disorder, Pharmaceutical industry, Nursing, Psychotherapy, Medicine, Trauma, Practitioner, Psychiatry

Red Cell Partners, an incubation firm building and investing in technology-led companies that bring revolutionary advancements to healthcare and national security, has announced $3 million in pre-seed funding for TARA Mind, a mental health company that enables safe and affordable access to psychedelic-assisted therapy (PAT).

Key Points: 
  • Red Cell Partners, an incubation firm building and investing in technology-led companies that bring revolutionary advancements to healthcare and national security, has announced $3 million in pre-seed funding for TARA Mind, a mental health company that enables safe and affordable access to psychedelic-assisted therapy (PAT).
  • The problem is a large and complicated one exacerbated by misaligned incentives, a global pandemic, and deep-rooted stigma surrounding psychedelics and other alternative therapies.
  • “Far too many people are being failed by our country’s outdated approach to mental health care,” said Red Cell CEO and TARA Mind Co-Founder, Grant Verstandig.
  • At TARA Mind, we aren’t being guided by ‘the buzz’ around psychedelics, nor are we chasing a quick profit from lingering loopholes in a post-COVID world.

Allurion Announces Premium Tiers for the Virtual Care Suite and Launch of Proprietary “My Daily Action” Bundle

Retrieved on: 
Wednesday, April 12, 2023
Health Technology, Telemedicine, Virtual Medicine, Technology, Apps, Applications, Other Consumer, General Health, Women, Artificial Intelligence, Fitness & Nutrition, Men, Wearables, Mobile Technology, Software, Consumer, Health, Mobile, Wireless, Obesity, Habit, VCS, Weight loss, Eating, Multimedia, Research, Movement, Pharmacotherapy, Behavioural sciences, Patient, Dietary supplement, Medical device

Allurion, a company dedicated to ending obesity, announced today the launch of premium tiers for the Virtual Care Suite and the launch of its proprietary “My Daily Action” bundle.

Key Points: 
  • Allurion, a company dedicated to ending obesity, announced today the launch of premium tiers for the Virtual Care Suite and the launch of its proprietary “My Daily Action” bundle.
  • By self-selecting a simple action to accomplish, repeating the action daily, and tracking compliance through the Allurion App, patients develop new, healthier long-term habits.
  • “We specifically designed this new Allurion App bundle using cutting-edge behavioral science to enhance the support offered to patients via the Virtual Care Suite.
  • Providers can upgrade to the premium packages at any time to take advantage of My Daily Actions.

University of Phoenix Bachelor’s of Science in Social Work Helps Prepare Students to Deliver Quality Care

Retrieved on: 
Monday, March 27, 2023
Education, Continuing, University, Council on Social Work Education, LCSW, Housing, Council for Higher Education Accreditation, BSSW, Curriculum, Doctor of Philosophy, University of Phoenix, Social, Student, Council, Behavioural sciences, Faculty, CSUSB College of Social and Behavioral Sciences, CHEA, CSWE, COA, Nursing, Science, College, Social work, Accreditation

University of Phoenix is pleased to share the continued success of its accredited baccalaureate social work program (BSSW), in the College of Social and Behavioral Sciences, in preparing students for the delivery of quality care in the field of social work.

Key Points: 
  • University of Phoenix is pleased to share the continued success of its accredited baccalaureate social work program (BSSW), in the College of Social and Behavioral Sciences, in preparing students for the delivery of quality care in the field of social work.
  • The University's BSSW program emphasizes substantive, relevant content, and meaningful opportunities for students to demonstrate and apply social work knowledge, values, and skills.
  • “I was working full-time when I entered the BSSW program at University of Phoenix, and being able to choose my start date was important.
  • University of Phoenix’s Bachelor’s of Science in Social Work (BSSW) program is offered online, with an in-person field education component, and does not require a residency.

Dr. Anita Thomas named 11th president of North Central College

Retrieved on: 
Tuesday, March 21, 2023
Psychology, Lynch School of Education and Human Development, Partnership, University, Education, Social justice, Senior counsel, North Central College, Lead, Woman, Research, Loyola University, Student, School, Humble High School, Behavioural sciences, St. Catherine, Faculty, St. Catherine University, Social work, Loyola University Chicago, Central College, University of Indianapolis, Nursing, Management, College, Northwestern University

NAPERVILLE, Ill., March 21, 2023 /PRNewswire/ -- Anita Thomas, Ph.D., has been selected as the 11th president of North Central College beginning July 1, 2023.

Key Points: 
  • NAPERVILLE, Ill., March 21, 2023 /PRNewswire/ -- Anita Thomas, Ph.D., has been selected as the 11th president of North Central College beginning July 1, 2023.
  • In North Central's 162-year history, Thomas is the first woman and the first person of color chosen to become the long-serving president.
  • "Having the opportunity to become part of this extraordinary institution is truly a great joy and honor," she said.
  • "A college campus is the best place to address diversity and equity issues, a place to 'unify diversity,'" she said.

Reejig Launches Talent Intent™ and Ethical Nudges™, Pioneering the Workforce Intelligence Category

Retrieved on: 
Tuesday, March 21, 2023
Workforce, Nobel Prize, Savage, Noise, Intelligence, Central nervous system, Bias, Organization, Gig, Behavioural sciences, SAN, HR, ROI, CO, Creative industries, Management

SAN FRANCISCO, March 21, 2023  /PRNewswire-PRWeb/ -- Reejig, the leading global workforce intelligence platform, today announced the launch of its Talent Intent™ and Ethical Nudges™ to help organizations proactively and seamlessly connect their candidates and employees to meaningful roles and gigs - increasing productivity and capacity across teams and reducing costly turnover.

Key Points: 
  • "The problem is that most organizations today don't have visibility into their workforce and don't know their people at all.
  • With Ethical Nudges , HR leaders and hiring managers can now connect people to new opportunities via automated highly personalized and contextual communications.
  • Talent Intent and Ethical Nudges are available immediately to all Reejig customers.
  • To learn more about Reejig's workforce intelligence platform visit reejig.com , or follow us on LinkedIn and Twitter .

PaxMedica Holds Meeting of Scientific Advisory Board

Retrieved on: 
Monday, March 20, 2023
University of California, San Diego Performance-Based Skills Assessment, Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices, Suramin, University, Pediatrics, State University of New York Upstate Medical University, Autism spectrum, Spectrum, Baylor University, Coronavirus Scientific Advisory Board, Doctor of Philosophy, Disorder, MD, Pathology, ASD, Behavioural sciences, Baylor College of Medicine, VCU School of Medicine, Pharmaceutical industry, Psychiatry, Medicine

TARRYTOWN, NY, March 20, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – PaxMedica, Inc. (Nasdaq: PXMD), a clinical stage biopharmaceutical company focusing on the development of novel anti-purinergic drug therapies (“APT”) for the treatment of disorders with intractable neurologic symptoms, today announced that it held a Scientific Advisory Board meeting on March 10-12, 2023.  A number of new members have been added to the board, which consists of many key opinion leaders in autism spectrum disorder (ASD) in the United States including:

Key Points: 
  • Board Includes Several Key Opinion Leaders on Autism Spectrum Disorder in U.S.
    TARRYTOWN, NY, March 20, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – PaxMedica, Inc. (Nasdaq: PXMD), a clinical stage biopharmaceutical company focusing on the development of novel anti-purinergic drug therapies (“APT”) for the treatment of disorders with intractable neurologic symptoms, today announced that it held a Scientific Advisory Board meeting on March 10-12, 2023.
  • We continue to be very excited about studying a product for the potential treatment of the core symptoms of autism spectrum disorder.”
    Dr. Robert Naviaux added, “At the scientific advisory board meeting this weekend, experts from many different areas of medicine came together to share their thoughts on how suramin may work in ASD and how it might work in several other complex disorders.
  • What emerged was a clear vision for the next steps needed to test suramin in autism.
  • This is expected to be done in a series of international, multicenter, clinical trials that are projected to begin in 2024.”

Northern Trust’s 2023 Wealth Planning Symposium to Focus on the Power of Resilience

Retrieved on: 
Thursday, March 16, 2023
Professional Services, Legal, Finance, Consulting, Banking, Accounting, Research, Private law, Divorce, Trustee, Behavioural sciences, Equal housing lender, FDIC, Trench, St. Jude Championship, Uncertainty, Tourism, Northern Trust

Northern Trust has announced its third annual Wealth Planning Symposium, which will bring together legal and financial experts to share innovative strategies and insights to shape the future of wealth management.

Key Points: 
  • Northern Trust has announced its third annual Wealth Planning Symposium, which will bring together legal and financial experts to share innovative strategies and insights to shape the future of wealth management.
  • The theme of this year’s symposium, “The Power of Resilience,” builds on The Northern Trust Institute’s 2023 Wealth Planning Outlook , which explores how individuals and families are continuing to harness the resilience that macroeconomic challenges and ongoing market uncertainty have demanded of them in recent years.
  • Wealth Planning and Behavioral Science: Learn how to incorporate leading behavioral science research to produce better outcomes for clients and help them avoid the pitfalls of intergenerational wealth planning.
  • “The Northern Trust Institute’s third annual Wealth Planning Symposium will delve into the essential ideas, solutions, and opportunities that today’s affluent individuals and families – and their team of advisers – should understand in order to build stronger, more purposeful wealth plans,” said Northern Trust Wealth Management President Steven L. Fradkin.